Grant of 100,000 shares worth of stock options to 204 directors within the company and directors\/employees of subsidiaries. Exercise period: October 1, 2028 to September 30, 2033. Total number of grant units: 1,000, with 100 shares per unit.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9267","jir_company_name":"Genkey Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/9267-20260910-01.pdf","jir_short_summary":"Grant of 100,000 shares worth of stock options to 204 directors within the company and directors\/employees of subsidiaries. Exercise period: October 1, 2028 to September 30, 2033. Total number of grant units: 1,000, with 100 shares per unit.","jir_summary":"### Background and overview of stock option issuance\nBased on the board resolution, we will issue stock options to internal directors and directors\/employees of our subsidiary. The objective is to improve consolidated performance and boost morale and business expansion. The target number of shares is 100,000, the total number of grant units is 1,000, and each unit grants 100 shares.\n\n### Exercise conditions, period, and adjustments\nThe exercise period for the stock options is from October 1, 2028 to September 30, 2033, with the last day being the preceding business day on non-business days of the shareholder register administrator. The exercise price is determined using the market closing price, with adjustments for stock splits and consolidations, and for declines in market value. Exercise conditions include service requirements and inheritance by succession, and acquisition upon transfer requires board approval.","jir_financial_highlights":"Total number of stock options: 1,000 shares (Unknown)\nNumber of granted shares: 100 shares (Unknown)\nNumber of recipients (internal directors): 204 people (Unknown)\nFair value calculation method for stock options: Black\u2013Scholes model (Unknown)","jir_category":"","jir_hashtags":"#GenkeeStockOption, #StockOptionIssuance","jir_key_figures":"Total stock acquisition rights: 1,000 units\nNumber of granted shares: 100 shares\/units\nNumber of recipients: 204 people","jir_meta_title":"Genkey Stock Options Granted | 204 recipients, term 2028-2033","jir_meta_description":"Genkey issues stock options to internal directors, subsidiary directors and employees. Total 1,000 units, 100 shares per unit, exercise period 2028-10-01 to 2033-09-30. Fair value calculated by Black\u2013Scholes model.","jir_og_title":"Genkey Stock Options Granted | 204 recipients, term 2028-2033","jir_og_description":"Issuance of stock options to executives and employees of internal and subsidiary entities. Total 1,000 units, 100 shares per unit, exercise period 2028-2033.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9174,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-112317","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n